Since FKBP51 has been implicated in different neurological disorders, including post-traumatic stress disorder and Alzheimer's disease [18], efforts are already underway to develop FKBP51-specific inhibitors [47–48]. The gene discussed is FKBP4; the disease is early-onset autosomal dominant Alzheimer disease.